Exact Mass: 277.0722

Exact Mass Matches: 277.0722

Found 452 metabolites which its exact mass value is equals to given mass value 277.0722, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

METAZACHLOR

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

C14H16ClN3O (277.0982)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 269 CONFIDENCE standard compound; INTERNAL_ID 3539 CONFIDENCE standard compound; INTERNAL_ID 8416 CONFIDENCE standard compound; INTERNAL_ID 4036 CONFIDENCE standard compound; INTERNAL_ID 31

Azathioprine

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine

C9H7N7O2S (277.0382)

Azathioprine is only found in individuals that have used or taken this drug. It is an immunosuppressive pro-drug. It is converted into 6-mercaptopurine in the body where it blocks purine metabolism and DNA synthesis.Azathioprine antagonizes purine metabolism and may inhibit synthesis of DNA, RNA, and proteins. It may also interfere with cellular metabolism and inhibit mitosis. Its mechanism of action is likely due to incorporation of thiopurine analogues into the DNA structure, causing chain termination and cytotoxicity. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Azathioprine (BW 57-322) is an orally active immunosuppressive agent. Azathioprine can be converted in vivo to the active metabolite 6-mercaptopurine (6-MP). Azathioprine has myelosuppressive effects and induces apoptosis[1][3].

Queuine

2-Amino-5-((((1S,4S,5R)-4,5-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-1,7-dihydro-4H-pyrrolo(2,3-D)pyrimidin-4-one

C12H15N5O3 (277.1175)

Queuine is a highly modified derivative of guanine found in the first position of the anticodon of the transfer RNAs for asp, asn, his and tyr. The original transcripts of these tRNAs contain guanine in this position. All organisms with the exception of yeast and mycoplasma contain queuine. Bacteria synthesize queuine but it cannot be synthesized by higher mammals. Significant amounts of free queuine are present in common plant and animal food products. (PMID 9016755) [HMDB] Queuine is a highly modified derivative of guanine found in the first position of the anticodon of the transfer RNAs for asp, asn, his and tyr. The original transcripts of these tRNAs contain guanine in this position. All organisms with the exception of yeast and mycoplasma contain queuine. Bacteria synthesize queuine but it cannot be synthesized by higher mammals. Significant amounts of free queuine are present in common plant and animal food products. (PMID 9016755).

S-(2-Methylpropionyl)-dihydrolipoamide-E

[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase]S-(2-methylpropanoyl)dihydrolipoyllysine

C12H23NO2S2 (277.117)

S-(2-Methylpropionyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15977). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 2-methyl-1-hydroxypropyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to isobutyryl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168]. [HMDB] S-(2-Methylpropionyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15977). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 2-methyl-1-hydroxypropyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to isobutyryl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168].

N-Phosphoguanidinoethyl methyl phosphate

N-phosphoguanidinoethyl methyl hydrogen phosphate

C4H13N3O7P2 (277.0229)

Pyrimidine 5-deoxynucleotide

C9H14N2O6P+ (277.0589)

Lycomarasmin

Lycomarasmine B

C9H15N3O7 (277.091)

trans-2-((Dimethylamino)methylimino)-5-(2-(5-nitro-2-furyl)vinyl)-1,3,4-oxadiazole

trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2- furyl)-vinyl]-1,3,4-oxadiazole

C11H11N5O4 (277.0811)

Arprinocid

C12H9ClFN5 (277.053)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent CONFIDENCE standard compound; INTERNAL_ID 1082

Deacetylbisacodyl

4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol

C18H15NO2 (277.1103)

JNJ-7777120

(5-chloro-1H-indol-2-yl)(4-methyl-1-piperazinyl)-methanone

C14H16ClN3O (277.0982)

JNJ-7777120 is a potent and selective histamine H4 receptor antagonist (Ki=4.5 nM). JNJ-7777120 effectively blocks histamine-induced migration of mouse tracheal mast cells from connective tissue to epithelial cells. JNJ-7777120 also significantly blocks neutrophil infiltration in a mouse Zymosan-induced peritonitis model. JNJ-7777120 has a good potential to study antipruritic and anti-inflammatory[1][2].

Dehydroaporheine

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14,16,18-heptaene

C18H15NO2 (277.1103)

Dehydroaporheine is found in coffee and coffee products. Dehydroaporheine is an alkaloid from Nelumbo nucifera (East India lotus) and Papaver rhoeas (corn poppy). Alkaloid from Nelumbo nucifera (East India lotus) and Papaver rhoeas (corn poppy). Dehydroaporheine is found in coffee and coffee products and root vegetables.

Murrayacine

3,11-dihydro-3,3-dimethylpyrano[3,2-a]Carbazole-5-carboxaldehyde, 9ci

C18H15NO2 (277.1103)

Murrayacine is found in herbs and spices. Murrayacine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Murrayacine is found in herbs and spices.

Methionyl-Glutamine

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoic acid

C10H19N3O4S (277.1096)

Methionyl-Glutamine is a dipeptide composed of methionine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

DOPA sulfate

(2S)-2-Amino-3-[4-hydroxy-3-(sulphooxy)phenyl]propanoic acid

C9H11NO7S (277.0256)

Increases in plasma dopamine sulfate and urinary dopamine suggest that dopamine sulfate may be generated via DOPA sulfate and urinary dopamine may originate from circulating DOPA. DOPA sulfate may be an alternative source of dopamine sulfate. Urinary dopamine progressively increased in the course of metyrosine treatment, and this, along with the increase of the dopamine metabolite, dihydroxyphenylethanol, and plasma dopamine sulfate, occurred in the absence of any change in plasma dopamine.(PMID: 1969915). Increases in plasma dopamine sulfate and urinary dopamine suggest that dopamine sulfate may be generated via DOPA sulfate and urinary dopamine may originate from circulating DOPA. DOPA sulfate may be an alternative source of dopamine sulfate.

Entecavir

2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one

C12H15N5O3 (277.1175)

Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS). Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

Arginylcysteine

(2R)-2-{[(2S)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-3-sulphanylpropanoic acid

C9H19N5O3S (277.1209)

Arginylcysteine is a dipeptide composed of arginine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Cysteinyl-Arginine

2-[(2-Amino-1-hydroxy-3-sulphanylpropylidene)amino]-5-carbamimidamidopentanoic acid

C9H19N5O3S (277.1209)

Cysteinyl-Arginine is a dipeptide composed of cysteine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Glutaminylmethionine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-4-(methylsulphanyl)butanoic acid

C10H19N3O4S (277.1096)

Glutaminylmethionine is a dipeptide composed of glutamine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Methionyl-Gamma-glutamate

2-Amino-4-{[2-amino-4-(methylsulphanyl)butanoyl]-C-hydroxycarbonimidoyl}butanoic acid

C10H19N3O4S (277.1096)

Methionyl-Gamma-glutamate is a dipeptide composed of methionine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Furilazole

2,2-Dichloro-1-[(5R)-5-(furan-2-yl)-2,2-dimethyl-1,3-oxazolidin-3-yl]ethan-1-one

C11H13Cl2NO3 (277.0272)

Furilazole (CAS: 121776-33-8) belongs to the class of organic compounds known as oxazolidines. Oxazolidines are compounds containing an oxazolidine moiety, which consists of a saturated aliphatic five-member ring with one oxygen atom, one nitrogen, three carbon atoms, and two double bonds. Furilazole is an extremely weak basic (essentially neutral) compound (based on its pKa). Furilazole is a dichloroacetamide herbicide safener for gramineous crops. Herbicide safener for gramineous crops

N-(1-Deoxy-1-fructosyl)proline

1-{[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}pyrrolidine-2-carboxylic acid

C11H19NO7 (277.1161)

Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)proline is classified as a Natural Food Constituent (code WA) in the DFC.

N-(2-hydroxymethyl-3-chlorophenyl)anthranilic acid

2-{[3-chloro-2-(hydroxymethyl)phenyl]amino}benzoic acid

C14H12ClNO3 (277.0506)

N-(2-hydroxymethyl-3-chlorophenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.

N-(2-methyl-3-chloro-4-hydroxyphenyl)anthranilic acid

2-[(3-chloro-4-hydroxy-2-methylphenyl)amino]benzoic acid

C14H12ClNO3 (277.0506)

N-(2-methyl-3-chloro-4-hydroxyphenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.

N-(2-methyl-3-chloro-5-hydroxyphenyl)anthranilic acid

2-[(3-chloro-5-hydroxy-2-methylphenyl)amino]benzoic acid

C14H12ClNO3 (277.0506)

N-(2-methyl-3-chloro-5-hydroxyphenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.

Metanephrine sulfate

{4-[1-hydroxy-2-(methylamino)ethyl]-2-methoxyphenyl}oxidanesulphonic acid

C10H15NO6S (277.062)

2-Naphthalenecarboxamide, 3-hydroxy-N-(2-methylphenyl)-

3-hydroxy-N-(2-methylphenyl)naphthalene-2-carboximidic acid

C18H15NO2 (277.1103)

2-Chloro-5-nitro-N-4-pyridinylbenzamide

2-chloro-5-nitro-N-(pyridin-4-yl)benzamide

C12H8ClN3O3 (277.0254)

T0070907 is a potent PPARγ antagonist with a Ki of 1 nM.

4-Nitrophenyl methylphenylphosphinate

4-Nitrophenyl methyl(phenyl)phosphinic acid

C13H12NO4P (277.0504)

Dihydroxydiphenyl-pyridyl methane

4-[(4-hydroxyphenyl)(pyridin-2-yl)methyl]phenol

C18H15NO2 (277.1103)

7-Hydroxyflumequine

7-fluoro-10-hydroxy-12-methyl-4-oxo-1-azatricyclo[7.3.1.0^{5,13}]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid

C14H12FNO4 (277.075)

Asparagine glutamate

4-amino-5-[(2-amino-3-carbamoylpropanoyl)peroxy]-5-oxopentanoic acid

C9H15N3O7 (277.091)

carboxy-ptio

[2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-3-oxido-4,5-dihydro-1H-imidazol-3-ium-1-yl]oxidanyl

C14H17N2O4 (277.1188)

3-[(2Z,3E)-3-(Hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one

C16H11N3O2 (277.0851)

Indirubin-3'-monoxime

3-nitroso-1H,1H-[2,3-biindole]-2-ol

C16H11N3O2 (277.0851)

Indirubin-3'-monoxime is a potent GSK-3β inhibitor, and weakly inhibits 5-Lipoxygenase, with IC50s of 22 nM and 7.8-10 μM, respectively; Indirubin-3'-monoxime also shows inhibitory activities against CDK5/p25 and CDK1/cyclin B, with IC50s of 100 and 180 nM.

1-[(5-Chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine

1-((5-Chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine

C14H16ClN3O (277.0982)

Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid

(-)-6-Phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid

C11H20NO5P (277.1079)

Necrostatin 2 racemate

5-[(7-chloro-1H-indol-3-yl)methyl]-3-methylimidazolidine-2,4-dione

C13H12ClN3O2 (277.0618)

Neridronic acid

(6-amino-1-hydroxy-1-phosphonohexyl)phosphonic acid

C6H17NO7P2 (277.048)

C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone

C13H8FNO5 (277.0386)

2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile

2-[8-(benzyloxy)-2-methylimidazo[1,2-a]pyridin-3-yl]acetonitrile

C17H15N3O (277.1215)

(2R,3S,5R)-5-(4,5-Dihydroimidazo[2,1-f]purin-3-yl)-2-(hydroxymethyl)oxolan-3-ol

C12H15N5O3 (277.1175)

3-Nitro-3,3a-dihydrobenzo[b]phenalen-7-one

14-nitrotetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,9,11,15-heptaen-8-one

C17H11NO3 (277.0739)

Sulfoxaflor

[Methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulphanylidene]cyanamide

C10H10F3N3OS (277.0497)

Arginyl-Cysteine

2-[(2-Amino-5-carbamimidamido-1-hydroxypentylidene)amino]-3-sulphanylpropanoic acid

C9H19N5O3S (277.1209)

4-(5-amino-6-benzylpyrazin-2-yl)phenol

4-(5-amino-6-benzyl-1H-pyrazin-2-ylidene)cyclohexa-2,5-dien-1-one

C17H15N3O (277.1215)

p-Toluolsulfonsaeure-(4-methylamino-phenyl)-ester|toluene-4-sulfonic acid-(4-methylamino-phenyl ester)|Toluol-4-sulfonsaeure-(4-methylamino-phenylester)

C14H15NO3S (277.0773)

3-hydroxyheteroendrin|Nitrile,2-O-beta-D-glucopyranoside-(R)-2,3-Dihydroxy-3-methylbutanoic acid

C11H19NO7 (277.1161)

Liriodenine

C17H11NO3 (277.0739)

2-[2-(Acetyloxy)phenyl]-4-thiazolecarboxylic acid methyl ester

C13H11NO4S (277.0409)

Gly Asp Ser

C9H15N3O7 (277.091)

Phthalyl-DL-glutamic Acid

C13H11NO6 (277.0586)

ppm-18

N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide

C17H11NO3 (277.0739)

Ala Met Gly

C10H19N3O4S (277.1096)

T0070907

2-chloro-5-nitro-N-4-pyridinyl-benzamide

C12H8ClN3O3 (277.0254)

T0070907 is a potent PPARγ antagonist with a Ki of 1 nM.

NSC118485

C9H15N3O7 (277.091)

Gly Ser Asp

C9H15N3O7 (277.091)

Ser Gly Asp

C9H15N3O7 (277.091)

Met Ala Gly

C10H19N3O4S (277.1096)

INDIRUBIN-3-MONOXIME

3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one

C16H11N3O2 (277.0851)

A member of the class of biindoles that is indirubin in which the keto group at position 3 has undergone condensation with hydroxylamine to form the corresponding oxime. Indirubin-3'-monoxime is a potent GSK-3β inhibitor, and weakly inhibits 5-Lipoxygenase, with IC50s of 22 nM and 7.8-10 μM, respectively; Indirubin-3'-monoxime also shows inhibitory activities against CDK5/p25 and CDK1/cyclin B, with IC50s of 100 and 180 nM.

Cys Val Gly

C10H19N3O4S (277.1096)

Gly Cys Val

C10H19N3O4S (277.1096)

azathioprine

"Azathioprine (Azasan, Imuran)"

C9H7N7O2S (277.0382)

L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2581; ORIGINAL_PRECURSOR_SCAN_NO 2579 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2599; ORIGINAL_PRECURSOR_SCAN_NO 2597 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2587; ORIGINAL_PRECURSOR_SCAN_NO 2585 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2583; ORIGINAL_PRECURSOR_SCAN_NO 2581 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2606; ORIGINAL_PRECURSOR_SCAN_NO 2603 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2606; ORIGINAL_PRECURSOR_SCAN_NO 2604 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5597; ORIGINAL_PRECURSOR_SCAN_NO 5595 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5599; ORIGINAL_PRECURSOR_SCAN_NO 5597 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5624; ORIGINAL_PRECURSOR_SCAN_NO 5622 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5605; ORIGINAL_PRECURSOR_SCAN_NO 5603 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5625; ORIGINAL_PRECURSOR_SCAN_NO 5623 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5634; ORIGINAL_PRECURSOR_SCAN_NO 5633 CONFIDENCE standard compound; INTERNAL_ID 8328 Azathioprine (BW 57-322) is an orally active immunosuppressive agent. Azathioprine can be converted in vivo to the active metabolite 6-mercaptopurine (6-MP). Azathioprine has myelosuppressive effects and induces apoptosis[1][3].

Methyltriphenylphosphonium

[C19H18P]+ (277.1146)

CONFIDENCE standard compound; INTERNAL_ID 2495

Coelenteramine

C17H15N3O (277.1215)

Etocrilene

Ethyl 2-cyano-3,3-diphenylacrylate

C18H15NO2 (277.1103)

C1892 - Chemopreventive Agent > C851 - Sunscreen CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9264; ORIGINAL_PRECURSOR_SCAN_NO 9261 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9311; ORIGINAL_PRECURSOR_SCAN_NO 9309 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9325; ORIGINAL_PRECURSOR_SCAN_NO 9323 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9368; ORIGINAL_PRECURSOR_SCAN_NO 9366 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9368; ORIGINAL_PRECURSOR_SCAN_NO 9367 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9377; ORIGINAL_PRECURSOR_SCAN_NO 9375

Methyl-imidazolidine-deoxycytidine

C9H15N3O7 (277.091)

Bisacodyl diphenol

4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol

C18H15NO2 (277.1103)

Asp Gly Ser

C9H15N3O7 (277.091)

Met Ala Gly

C10H19N3O4S1 (277.1096)

Gly Ala Met

C10H19N3O4S1 (277.1096)

Cys Gly Val

C10H19N3O4S1 (277.1096)

Gly Cys Val

C10H19N3O4S1 (277.1096)

Ser Asp Gly

C9H15N3O7 (277.091)

Cys Val Gly

C10H19N3O4S1 (277.1096)

Gly Val Cys

C10H19N3O4S1 (277.1096)

Asp Ser Gly

C9H15N3O7 (277.091)

Ala Gly Met

C10H19N3O4S1 (277.1096)

Met Gly Ala

C10H19N3O4S1 (277.1096)

Gly Met Ala

C10H19N3O4S1 (277.1096)

Ala Met Gly

C10H19N3O4S1 (277.1096)

Val Gly Cys

C10H19N3O4S1 (277.1096)

Val Cys Gly

C10H19N3O4S1 (277.1096)

Cys Arg

C9H19N5O3S1 (277.1209)

Gln Met

C10H19N3O4S1 (277.1096)

Arg Cys

C9H19N5O3S1 (277.1209)

Met Gln

C10H19N3O4S1 (277.1096)

2-phthalimidoglutaric acid

Pentanedioic acid,2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-

C13H11NO6 (277.0586)

DOPA sulfate

3,4-dihydroxy-L-phenylalanine 3-O-sulfate;L-3-hydroxytyrosine 3-sulfate;3-(3-sulfo-4-hydroxy-phenyl)-L-alanine

C9H11NO7S (277.0256)

S-(2-Methylpropionyl)-dihydrolipoamide-E

[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase]S-(2-methylpropanoyl)dihydrolipoyllysine

C12H23NO2S2 (277.117)

Entecavir

2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one

C12H15N5O3 (277.1175)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

Arg-cys

2-(2-amino-3-sulfanylpropanamido)-5-carbamimidamidopentanoic acid

C9H19N5O3S (277.1209)

Cys-arg

2-(2-amino-5-carbamimidamidopentanamido)-3-sulfanylpropanoic acid

C9H19N5O3S (277.1209)

GLN-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C10H19N3O4S (277.1096)

Met-GLN

2-(2-amino-4-carbamoylbutanamido)-4-(methylsulfanyl)butanoic acid

C10H19N3O4S (277.1096)

A dipeptide formed from L-methionine and L-glutamine residues.

Met-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-4-(methylsulfanyl)butanoic acid

C10H19N3O4S (277.1096)

GGlu-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-4-(C-hydroxycarbonimidoyl)butanoic acid

C10H19N3O4S (277.1096)

Dehydroremerine

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0^{2,6}.0^{8,20}.0^{14,19}]icosa-1,6,8(20),12,14,16,18-heptaene

C18H15NO2 (277.1103)

Murrayacine

3,11-dihydro-3,3-dimethylpyrano[3,2-a]Carbazole-5-carboxaldehyde, 9ci

C18H15NO2 (277.1103)

Furilazole

2,2-dichloro-1-[5-(furan-2-yl)-2,2-dimethyl-1,3-oxazolidin-3-yl]ethan-1-one

C11H13Cl2NO3 (277.0272)

Methyl (S)-1-Cbz-4-oxo-2-pyrrolidinecarboxylate

C14H15NO5 (277.095)

N-phthaloyl-L-glutamic acid

C13H11NO6 (277.0586)

S-Methyl-L-thiocitrulline dihydrochloride

(S,E)-2-Amino-5-((amino(methylthio)methylene)amino)pentanoic acid dihydrochloride

C7H17Cl2N3O2S (277.0418)

(2-AMINO-4,7-DIMETHYL)BENZOTHIAZOL-6-OL,HCL

C14H12ClNOS (277.0328)

chembrdg-bb 6966505

C13H11NO4S (277.0409)

AKOS B018249

C13H11NO2S2 (277.0231)

ethyl 3-amino-5-(4-methoxyphenyl)thiophene-2-carboxylate

C14H15NO3S (277.0773)

4-[[(2,5-dimethylfuran-3-carbonyl)amino]methyl]-5-methylfuran-2-carboxylic acid

C14H15NO5 (277.095)

2-(2,4-dimethylphenyl)quinoline-4-carboxylic acid

C18H15NO2 (277.1103)

4-Quinolinecarboxylicacid, 3-methyl-2-phenyl-, methyl ester

C18H15NO2 (277.1103)

5-propan-2-yl-7-(trifluoromethyl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C11H14F3N3O2 (277.1038)

(7-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)b oronic acid

C13H16BNO5 (277.1121)

(6-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)b oronic acid

C13H16BNO5 (277.1121)

(5-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)b oronic acid

C13H16BNO5 (277.1121)

Sulfoxaflor

C10H10F3N3OS (277.0497)

Sulfoxaflor is a sulfoximine insecticide and is an agonist of nAChR1 and nAChR2 subtypes. Sulfoxaflor is used for the control of sap-feeding insects such as Myzus persicae, Aphis gossypii, Bemissia tabaci and Nilaparvata lugens[1].

methyl 5,5,5-trifluoro-4-(4-fluorophenyl)iminopentanoate

C12H11F4NO2 (277.0726)

Methyl 5,5,5-trifluoro-4-(4-fluorophenylamino)pent-3-enoate

C12H11F4NO2 (277.0726)

2-[(3,5-DICHLORO-2-HYDROXYBENZYLIDENE)AMINO]-2-METHYLPROPANE-1,3-DIOL

C11H13Cl2NO3 (277.0272)

Guanidine,N-(4-chlorophenyl)-N-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-

C12H12ClN5O (277.073)

Iproniazid phosphate

Iproniazid (phosphate)

C9H16N3O5P (277.0828)

4-phenylazomaleinanil

C16H11N3O2 (277.0851)

3-BENZENESULFONYLAMINOBENZOICACID

C13H11NO4S (277.0409)

6-(4-Methanesulfonylphenyl)-nicotinic acid

C13H11NO4S (277.0409)

tert-Butyl 4-(bromomethyl)piperidine-1-carboxylate

C11H20BrNO2 (277.0677)

METHYL CALCEIN BLUE

C14H15NO5 (277.095)

6-METHYL-2-(2-METHYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H15NO2 (277.1103)

6-Methyl-2-(3-methylphenyl)quinoline-4-carboxylic acid

C18H15NO2 (277.1103)

8-METHYL-2-(2-METHYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H15NO2 (277.1103)

8-Methyl-2-(3-methylphenyl)quinoline-4-carboxylic acid

C18H15NO2 (277.1103)

8-METHYL-2-(4-METHYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H15NO2 (277.1103)

2,5-Cyclohexadien-1-one,4-[[4-hydroxy-2-methyl-5-(1-methylethyl)phenyl]imino]-, sodium salt (1:1)

C16H16NNaO2 (277.1079)

4-(phenylsulfamoyl)benzoate

C13H11NO4S (277.0409)

Polyimilex PS

C18H15NO2 (277.1103)

11H-Benzo[a]carbazole-3-carboxylicacid, 2-hydroxy-

C17H11NO3 (277.0739)

1-Bromo-3-chloro-5,5-dimethylhydantoin

C12H17Cl2NO2 (277.0636)

2-Amino-N-(5-chloro-2-pyridinyl)-5-methoxybenzamide

C13H12ClN3O2 (277.0618)

4-(2-Formylphenoxy)benzenesulfonamide

C13H11NO4S (277.0409)

methyl 2-{[(benzyloxy)carbonyl]amino}-2-(oxetan-3-ylidene)acetate

C14H15NO5 (277.095)

2-(3H-1,3-benzothiazol-2-ylidene)naphthalen-1-one

C17H11NOS (277.0561)

1-Pyrrolidinecarboxylic acid, 3-(2-bromoethyl)-, 1,1-dimethylethyl ester

C11H20BrNO2 (277.0677)

5-(2-FURYL)-3-THIEN-2-YL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE

C12H11N3OS2 (277.0344)

2-Diphenylphosphino-6-methylpyridine

C18H16NP (277.102)

Folescutol

C14H15NO5 (277.095)

Methyl 1-(6-chloropyridin-2-yl)-5-cyclopropyl-1H-pyrazole-4-carboxylate

C13H12ClN3O2 (277.0618)

Pentanoic acid, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-4-methyl-, (2S)-

C14H15NO5 (277.095)

N-(2-methyl-5-phenylpyrrol-1-yl)pyridine-4-carboxamide

C17H15N3O (277.1215)

5-Quinoxalinecarboxamide,N-(2-phenylethyl)-(9CI)

C17H15N3O (277.1215)

(1R, 3S, 4R)-ent-Entecavir

C12H15N5O3 (277.1175)

Ethyl 5-acetyl-6-oxo-2-(trifluoromethyl)-1,6-dihydro-3-pyridineca rboxylate

C11H10F3NO4 (277.0562)

ssh-108

C10H17F2N5S (277.1173)

[3-(3-chloropropylsulfonylamino)phenyl]boronic acid

C9H13BClNO4S (277.0347)

4-OXO-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-BENZYL ESTER

C14H15NO5 (277.095)

Inamrinone lactate

C13H15N3O4 (277.1063)

Pyridinium,2-methyl-1-(2-phenylethyl)-, bromide (1:1)

C14H16BrN (277.0466)

1-[1-(CYCLOPROPYLMETHYL)-4-PIPERIDINYL]METHANAMINE

C10H16BrNO3 (277.0313)

2-SULFAMOYL-BIPHENYL-4-CARBOXYLICACID

C13H11NO4S (277.0409)

PHTHALIMIDOPEROXYCAPROIC ACID

C14H15NO5 (277.095)

3-Bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester

C10H16BrNO3 (277.0313)

4-(n-(3-chloropropyl)sulfamoyl)phenylboronic acid

C9H13BClNO4S (277.0347)

(4-(4-Fluoro-2-nitrophenoxy)phenyl)boronic acid

C12H9BFNO5 (277.0558)

2-tert-butyl-7-chloro-5-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine

C11H11ClF3N3 (277.0594)

4-(Maleimido)benzophenone

C17H11NO3 (277.0739)

4-(2-carboxyethyl)-4-nitroheptanedioic acid

C10H15NO8 (277.0798)

2-AMINO-4-(4-ETHOXYPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER

C14H15NO3S (277.0773)

2-Chloro-N-(2-phenylsulfanyl-phenyl)-acetamide

C14H12ClNOS (277.0328)

Alipamide

C9H12ClN3O3S (277.0288)

C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

5-[(3-Methoxyphenylamino)Methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione

C14H15NO5 (277.095)

tert-butyl 2-(bromomethyl)piperidine-1-carboxylate

C11H20BrNO2 (277.0677)

4-chloro-3-[[(4-methoxyphenyl)methylamino]methyl]pyridin-2-amine

C14H16ClN3O (277.0982)

ETHYL 2-METHYL-2-((5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)OXY)PROPANOATE

C12H14F3NO3 (277.0926)

ethyl 5-amino-3-methylsulfanyl-1-phenylpyrazole-4-carboxylate

C13H15N3O2S (277.0885)

N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine

C14H10F3N3 (277.0827)

Benzyltrimethylammonium iodide

C10H16IN (277.0327)

3-BENZOYLQUINOLINE-4-CARBOXYLICACID

C17H11NO3 (277.0739)

4-(4-CARBAMOYLPIPERAZINE-1-CARBONYL)BENZOICACID

C13H15N3O4 (277.1063)

2,2:6,2-TERPYRIDINE]-4-CARBOXYLIC ACID

C16H11N3O2 (277.0851)

(S)-TERT-BUTYL 3-(BROMOMETHYL)PIPERIDINE-1-CARBOXYLATE

C11H20BrNO2 (277.0677)

5-chloro-cytidine

C9H12ClN3O5 (277.0465)

6,7-DIETHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

C14H15NO5 (277.095)

Z-Val-NCA

C14H15NO5 (277.095)

Tert-Butyl (4-(Trifluoromethoxy)Phenyl)Carbamate

C12H14F3NO3 (277.0926)

1,4-Naphthalenedione,2-chloro-3-(4-morpholinyl)-

C14H12ClNO3 (277.0506)

K 858

N-(4-acetyl-5-methyl-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide

C13H15N3O2S (277.0885)

5-Benzylsulfonyl-2-methoxy-aniline

C14H15NO3S (277.0773)

1-BOC-3-BROMOMETHYLPIPERIDINE

C11H20BrNO2 (277.0677)

5-Acetyl-8-(phenylmethoxy)quinoline

C18H15NO2 (277.1103)

2-AMINO-1-(3-(BENZYLOXY)PHENYL)ETHANONE HYDROCHLORIDE

C15H16ClNO2 (277.087)

4-(4-Methoxyphenyl)-6-phenyl-2-pyrimidinamine

C17H15N3O (277.1215)

Pentanoic acid, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-4-methyl-,(2R)-

C14H15NO5 (277.095)

2-(1H-BENZIMIDAZOL-2-YLTHIO)ANILINE HYDROCHLORIDE

C13H12ClN3S (277.044)

N-(4-HYDROXY-PHENYL)-4,N-DIMETHYL-BENZENESULFONAMIDE

C14H15NO3S (277.0773)

2-[difluoro(phenoxy)methyl]-1,3-benzothiazole

C14H9F2NOS (277.0373)

INDOLO[2,3-B]QUINOXALIN-6-YL-ACETIC ACID

C16H11N3O2 (277.0851)

1-(Piperidin-4-yl)piperazine trihydrochloride

C9H22Cl3N3 (277.0879)

2-BENZENESULFONYLAMINO-BENZOIC ACID

C13H11NO4S (277.0409)

5-(3-Chlorobenzyl)-4-ethoxy-6-methyl-2-pyrimidinamine

C14H16ClN3O (277.0982)

L-Carnitine fumarate

C11H19NO7 (277.1161)

2-(Methylsulfonyl)-10H-phenothiazine

C13H11NO2S2 (277.0231)

2,2-[(4-Amino-3-nitrophenyl)imino]bisethanol hydrochloride

C10H16ClN3O4 (277.0829)

1H-Indene-1,3(2H)-dione,2-[[4-(dimethylamino)phenyl]methylene]-

C18H15NO2 (277.1103)

3-(2-Bromoacetamido)-Proxyl, Free Radical

C10H18BrN2O2 (277.0552)

4-Chloro-3-cyano-7-ethoxy-6-nitroquinoline

C12H8ClN3O3 (277.0254)

3-(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methyl-1,2,4-oxadiaz ole-5-carboxamide

C11H8ClN5O2 (277.0366)

1-CYCLOHEXYL-1-TOSYLMETHYL ISOCYANIDE

C15H19NO2S (277.1136)

1,2-Ethanedione, 1-(6-Methyl-2-pyridinyl)-2-(6-quinoxalinyl)-

C16H11N3O2 (277.0851)

4-(morpholin-4-yl)benzenediazonium tetrafluoroborate

C10H12BF4N3O (277.101)

ETHYL 2-(BENZO[D][1,3]DIOXOL-5-YL)THIAZOLE-4-CARBOXYLATE

C13H11NO4S (277.0409)

3-(1-(phenylsulfonyl)-1H-pyrrol-2-yl)acrylic acid

C13H11NO4S (277.0409)

Sodium theophylline glycinate

C9H12N5NaO4 (277.0787)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Ethyl 2-amino-4-(4-methoxyphenyl)-3-thiophenecarboxylate

C14H15NO3S (277.0773)

(3R,4R)-N-CBZ-3,4-DIFLUOROPYRROLIDINEHYDROCHLORIDE

C12H14ClF2NO2 (277.0681)

AKOS B018345

C14H15NOS2 (277.0595)

2,5-DIOXOPYRROLIDIN-1-YL METHYL PHTHALATE

C13H11NO6 (277.0586)

2-(3,4-DIMETHYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H15NO2 (277.1103)

2-[(7-hydroxy-4-methyl-2-oxo-chromen-6-yl)methyl-methyl-ammonio]acetate

C14H15NO5 (277.095)

6-Ethyl-2-phenylquinoline-4-carboxylic acid

C18H15NO2 (277.1103)

2-Chloro-N-(3-nitrophenyl)-4-pyridinecarboxamide

C12H8ClN3O3 (277.0254)

methyl (E)-3-(2-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C13H12ClN3O2 (277.0618)

2-(METHYLTHIO)-4-[(2-METHOXYPHENYL)AMINO]-5-PYRIMIDINEMETHANOL

C13H15N3O2S (277.0885)

Benzene-1,4-diboronic acid mono-MIDA ester

C11H13B2NO6 (277.0929)

5-((4-(DIMETHYLAMINO)PHENYL)IMINO)-8(5H&

C17H15N3O (277.1215)

TERT-BUTYL (3,6-DICHLOROPYRIDAZIN-4-YL)METHYLCARBAMATE

C10H13Cl2N3O2 (277.0385)

ethyl 2-phenylquinoline-4-carboxylate

C18H15NO2 (277.1103)

1,5-DIPHENYL-2-METHYLPYRROLE-3-CARBOXYLIC ACID

C18H15NO2 (277.1103)

2-AMINO-4-(4-METHOXY-PHENYL)-5-METHYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER

C14H15NO3S (277.0773)

2-AMINO-2-(3,4,5-TRIMETHOXYPHENYL)ACETIC ACID HYDROCHLORIDE

C11H16ClNO5 (277.0717)

HA-100

1-(5-Isoquinolinesulfonyl)piperazine

C13H15N3O2S (277.0885)

4-(PHENYLSULFONAMIDO)BENZOIC ACID

C13H11NO4S (277.0409)

2-(2,5-DIMETHYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H15NO2 (277.1103)

Benzoic acid,4-chloro-2-[(4-methoxyphenyl)amino]-

C14H12ClNO3 (277.0506)

Acetamide,2-bromo-N-decyl-

C12H24BrNO (277.1041)

(2,4-DICHLORO-5-(2-(DIMETHYLAMINO)ETHOXY)PHENYL)BORONIC ACID

C10H14BCl2NO3 (277.0444)

5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C14H17BClNO2 (277.1041)

2-AMINO-4-(5-METHYLFURAN-2-YL)-5H-INDENO[1,2-D]PYRIMIDIN-5-ONE

C16H11N3O2 (277.0851)

(4-(1-piperidinylmethyl)phenyl)magnesiu&

C12H16BrMgN (277.0317)

Ethylmethylthiambutene

N-ethyl-N-methyl-4,4-dithiophen-2-ylbut-3-en-2-amine

C15H19NS2 (277.0959)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

1-BENZHYDRYL-3-FLUORO-AZETIDINEHYDROCHLORIDE

C16H17ClFN (277.1033)

N-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)HYDRAZINECARBOTHIOAMIDE

C12H15N5OS (277.0997)

Ganciclovir sodium

C9H12N5NaO4 (277.0787)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

HJC 0350

C15H19NO2S (277.1136)

D-Glucosamine sulphate

C6H15NO9S (277.0468)

ETHYL 3-(2-CARBOXY-VINYL)-5-FLUORO-1H-INDOLE-2-CARBOXYLATE

C14H12FNO4 (277.075)

DL-3-(4-BIPHENYL)ALANINE HYDROCHLORIDE

C15H16ClNO2 (277.087)

2,4,5-TRIFLUORO-N-(1-HYDROXY-2-METHYL PROPAN-2-YL)-3-METHOXYBENZAMIDE

C12H14F3NO3 (277.0926)

(1R,3R,4R)-Entecavir

C12H15N5O3 (277.1175)

2-Amino-9-[(1S,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one

C12H15N5O3 (277.1175)

C13H15N3O4

C13H15N3O4 (277.1063)

N-(2-Chloropyridin-3-yl)-2-nitrobenzamide

C12H8ClN3O3 (277.0254)

2-AMINO-4-BENZYLOXYACETOPHENONE HYDROCHLORIDE

C15H15NO2.ClH (277.087)

1-Epi-Entecavir

C12H15N5O3 (277.1175)

(1S,3S,4R)-Entecavir

C12H15N5O3 (277.1175)

2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one

C12H15N5O3 (277.1175)

(R)-2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID

C11H10F3NO2S (277.0384)

4-(1H-BENZIMIDAZOL-2-YL)-1-PHENYLPYRROLIDIN-2-ONE

C17H15N3O (277.1215)

ethyl 5-amino-4-(2-nitrophenyl)-1,2-oxazole-3-carboxylate

C12H11N3O5 (277.0699)

7-Chloro-1-cyclopropyl-1,4-dihydro-8-Methyl-4-oxo-3-quinolinecarboxylic Acid

C14H12ClNO3 (277.0506)

4-Chloroindole-2-boronic acid, pinacol ester

C14H17BClNO2 (277.1041)

Isopropyl 2-(3-Nitrobenzylidene)acetoacetate

C14H15NO5 (277.095)

ethyl 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxylate

C15H16ClNO2 (277.087)

N-(4-formyl-3-hydroxyphenyl)benzenesulphonamide

C13H11NO4S (277.0409)

4-ALLYL-5-[(4-METHOXYPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL

C13H15N3O2S (277.0885)

2-(Diphenylphosphino)phenylamine

C18H16NP (277.102)

3-hydroxy-N-(4-methylphenyl)naphthalene-2-carboxamide

C18H15NO2 (277.1103)

azure C

C13H12ClN3S (277.044)

D004396 - Coloring Agents > D001399 - Azure Stains

(3-((3,4-Difluorophenyl)carbamoyl)phenyl)boronic acid

C13H10BF2NO3 (277.0722)

(3-(4-FLUORO-2-NITROPHENOXY)PHENYL)BORONIC ACID

C12H9BFNO5 (277.0558)

7-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C14H17BClNO2 (277.1041)

(3-(1-piperidinylmethyl)phenyl)magnesiu&

C12H16BrMgN (277.0317)

Ethanone,1-(4-methoxyphenyl)-2-(2-quinolinyl)-

C18H15NO2 (277.1103)

1-(4-AMINOBENZYL)GUANIDINEHYDROCHLORIDE

C17H15N3O (277.1215)

(R)-TERT-BUTYL 3-(BROMOMETHYL)PIPERIDINE-1-CARBOXYLATE

C11H20BrNO2 (277.0677)

1,2,3,4-TETRAHYDRO-6-METHYL-4-(4-NITROPHENYL)-2-OXO-5-PYRIMIDINECARBOXYLIC ACID

C12H11N3O5 (277.0699)

1-(4-Boronobenzoyl)piperidine-4-carboxylic acid

C13H16BNO5 (277.1121)

m-[(p-Aminophenyl)azo]benzenesulphonic acid

C12H11N3O3S (277.0521)

Amfenac sodium

SODIUM 2-(2-AMINO-3-BENZOYLPHENYL)ACETATE

C15H12NNaO3 (277.0715)

1-(2-Methyl-3-nitrophenyl)-4-oxocyclohexanecarboxylic acid

C14H15NO5 (277.095)

1-CYCLOPROPYL-7-FLUORO-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

C14H12FNO4 (277.075)

1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine

C14H16BrN (277.0466)

4-[3-(3-Nitrophenyl)-1,2,4-oxadiazol-5-YL]butanoic acid

C12H11N3O5 (277.0699)

Levodopa-4-monophosphate

C9H12NO7P (277.0351)

C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

Durlobactam

C8H11N3O6S (277.0369)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic D004791 - Enzyme Inhibitors

Alrestatin sodium

C14H8NNaO4 (277.0351)

C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor

(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone

C13H8FNO5 (277.0386)

2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile

C17H15N3O (277.1215)

D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors

Benzoic acid, p-(2-methyl-5-phenylpyrrol-1-yl)-

C18H15NO2 (277.1103)

ProINDY

C14H15NO3S (277.0773)

N-(4-phenylmethoxyphenyl)methanesulfonamide

C14H15NO3S (277.0773)

2-chloro-N-(1-phenyl-3-propyl-1H-pyrazol-5-yl)acetamide

C14H16ClN3O (277.0982)

Bis(2-methylphenyl) phosphate

C14H14O4P- (277.063)

2-amino-N-(4-ethylphenyl)-4-oxo-5,6-dihydro-4H-1,3-thiazine-6-carboxamide

C13H15N3O2S (277.0885)

3-(3,5-dimethoxyphenyl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

C13H15N3O2S (277.0885)

ethyl 2-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]acetate

C14H15NO5 (277.095)

N-(7-methyl-2-thiazolo[4,5-g][1,3]benzothiazolyl)propanamide

C12H11N3OS2 (277.0344)

Triphenylmethylphosphonium

C19H18P+ (277.1146)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

alpha-Benzyl-aminobenzyl-phosphonic acid

C14H16NO3P (277.0868)

2-(5-Hydroxy-naphthalen-1-YL)-1,3-benzooxazol-6-OL

C17H11NO3 (277.0739)

3-(6-Hydroxy-naphthalen-2-YL)-benzo[D]isooxazol-6-OL

C17H11NO3 (277.0739)

(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one

C13H15N3O2S (277.0885)

3-[5-(3-Nitrophenyl)thiophen-2-yl]propanoic acid

C13H11NO4S (277.0409)

N-(1-Benzyl-3,3,3-trifluoro-2,2-dihydroxy-propyl)-acetamide

C12H14F3NO3 (277.0926)

Amrinone lactate

C13H15N3O4 (277.1063)

Amrinone ethylenelactate

C13H15N3O4 (277.1063)

Neopentalenoketolactone

C15H17O5- (277.1076)

2-Amino-5-[[[(1S,4S,5R)-4,5-dihydroxy-2-cyclopenten-1-yl]amino]methyl]-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one Dihydrochloride

C12H15N5O3 (277.1175)

pentalenolactone F(1-)

C15H17O5- (277.1076)

A monocarboxylic acid anion that is the conjugate base of pentalenolactone F, obtained by deprotonation of the carboxy group; major species at pH 7.3.

neopentalenolactone F

C15H17O5- (277.1076)

gamma-Glutamylmethioninate

C10H17N2O5S- (277.0858)

O-citryl-serine

C9H11NO9-2 (277.0434)

5-Hydroxyindole thiazolidine carboxylic acid

C13H13N2O3S- (277.0647)

(alphaS)-alpha-Carboxy-2,3-dihydro-N,N,N-trimethyl-2-selenoxo-1H-imidazole-4-ethanaminium

C9H15N3O2Se+ (277.0329)

S-(8-amino-8-oxo-1-sulfanyloctan-3-yl) 2-methylpropanethioate

C12H23NO2S2 (277.117)

2-Amino-5-((((1S,4S,5R)-4,5-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-1,7-dihydro-4H-pyrrolo(2,3-D)pyrimidin-4-one

C12H15N5O3 (277.1175)

4-Amino-5-(2,4-diamino-4-oxobutanoyl)peroxy-5-oxopentanoic acid

C9H15N3O7 (277.091)

(2R,3S,5R)-5-(4,5-Dihydroimidazo[2,1-f]purin-3-yl)-2-(hydroxymethyl)oxolan-3-ol

C12H15N5O3 (277.1175)

N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide

C13H15N3O2S (277.0885)

N-[4-cyano-2-(1-naphthalenyl)-5-oxazolyl]acetamide

C16H11N3O2 (277.0851)

3-[(6-Methoxy-4-methyl-2-quinolinyl)thio]propanoic acid

C14H15NO3S (277.0773)

2-(4-Oxo-6,8-dioxabicyclo[3.2.1]octan-2-yl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione

C14H15NO5 (277.095)

2,6-Dimethyl-4-(3-thienyl)pyridine-3,5-dicarboxylic acid

C13H11NO4S (277.0409)

[methyl-oxo-[(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]-lambda6-sulfanylidene]cyanamide

C10H10F3N3OS (277.0497)

Glutaminylmethionine

C10H19N3O4S (277.1096)

Gly-Asp-Ser

C9H15N3O7 (277.091)

Cys-Gly-Val

C10H19N3O4S (277.1096)

Bis(4-methylphenyl) phosphate

C14H14O4P- (277.063)

1-Isobutylsulfanylmethyl-2,8,9-trioxa-5-aza-1-sila-bicyclo[3.3.3]undecane

C11H23NO3SSi (277.1168)

2-Nitrobenzaldehyde (3-chloro-2-pyrazinyl)hydrazone

C11H8ClN5O2 (277.0366)

[methyl-oxo-[(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]-lambda6-sulfanylidene]cyanamide

C10H10F3N3OS (277.0497)

Met-Ala-Gly

C10H19N3O4S (277.1096)

Ser-Gly-Asp

C9H15N3O7 (277.091)

Ser-Asp-Gly

C9H15N3O7 (277.091)

Gly-Ala-Met

C10H19N3O4S (277.1096)

Asp-Gly-Ser

C9H15N3O7 (277.091)

Gly-Cys-Val

C10H19N3O4S (277.1096)

Gly-Ser-Asp

C9H15N3O7 (277.091)

Gly-Val-Cys

C10H19N3O4S (277.1096)

Egualen(1-)

C15H17O3S- (277.0898)

N-purin-6-oyl-6-aminocaproic acid

C12H15N5O3 (277.1175)

2-(p-Chlorophenyl)-3-ethyl-2,5-dihydro-5-oxo-4-pyridazinecarboxylate

C13H10ClN2O3- (277.038)

1-[(5S)-2,2-Dimethyl-5-(2-furanyl)oxazolidin-3-yl]-2,2-dichloroethanone

C11H13Cl2NO3 (277.0272)

5-[(3-Methoxyphenyl)iminomethyl]-2,2-dimethyl-1,3-dioxane-4,6-dione

C14H15NO5 (277.095)

Asp-ser-gly

C9H15N3O7 (277.091)

Clenbuterol(1+)

C12H19Cl2N2O+ (277.0874)

Val-Cys-Gly

C10H19N3O4S (277.1096)

Ala-Met-Gly

C10H19N3O4S (277.1096)

Ala-Gly-Met

C10H19N3O4S (277.1096)

Cys-Val-Gly

C10H19N3O4S (277.1096)

Gly-Met-Ala

C10H19N3O4S (277.1096)

Met-Gly-Ala

C10H19N3O4S (277.1096)

Val-Gly-Cys

C10H19N3O4S (277.1096)

Cidofovir(2-)

C8H12N3O6P-2 (277.0464)

6-Amino-1-benzyl-3-methyl-5-(oxidoamino)-2-sulfanylidenepyrimidin-4-one

C12H13N4O2S- (277.0759)

8-Quinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

6-Quinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

7-Quinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

3-Quinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

4-Quinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

5-Quinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

3-Isoquinolylmethyl 2-methylbenzoate

C18H15NO2 (277.1103)

Queuine

C12H15N5O3 (277.1175)

S(8)-(2-methylpropanoyl)dihydrolipoamide

C12H23NO2S2 (277.117)

Lycomarasmine

C9H15N3O7 (277.091)

N-phosphoguanidinoethyl methyl hydrogen phosphate

C4H13N3O7P2 (277.0229)

Neridronate

Neridronic acid

C6H17NO7P2 (277.048)

C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

Selenoneine

C9H15N3O2Se (277.0329)

A histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine substituted by a selenoxo group at position 2 on the imidazole ring. A selenium-containing antioxidant found in tuna blood.

gamma-Glu-Met(1-)

C10H17N2O5S (277.0858)

A peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of gamma-Glu-Met. Major species at pH 7.3.

METAZACHLOR

C14H16ClN3O (277.0982)

Dehydroaporheine

C18H15NO2 (277.1103)

Oxazolidine, 3-(dichloroacetyl)-5-(2-furanyl)-2,2-dimethyl-, (5R)-

C11H13Cl2NO3 (277.0272)

carboxy-ptio

C14H17N2O4 (277.1188)

A mmeber of the class of imidazolines and organic radical that is 4,4,5,5-tetramethyl-3-oxo-4,5-dihydro-1H-3lambda(5)-imidazol-1-yl]oxidanyl substituted at position 2 by a 4-carboxyphenyl group.

N-(2-methyl-3-chloro-4-hydroxyphenyl)anthranilic acid

C14H12ClNO3 (277.0506)

Cysteinyl-Arginine

C9H19N5O3S (277.1209)

Arginylcysteine

C9H19N5O3S (277.1209)

Arginyl-cysteine

C9H19N5O3S (277.1209)

N-(1-Deoxy-1-fructosyl)proline

C11H19NO7 (277.1161)

Methionylgamma-glutamate

C10H19N3O4S (277.1096)

Cyclo(Asn-Tyr)

C13H15N3O4 (277.1063)

Di-o-cresylphosphate

C14H14O4P (277.063)

Di-p-cresylphosphate

C14H14O4P (277.063)

2-Phthalimidoglutaricacid

C13H11NO6 (277.0586)

Phthalimidoglutaricacid

C13H11NO6 (277.0586)

Glucosamine (sulfate)

C6H15NO9S (277.0468)

Glucosamine sulfate (D-Glucosamine sulfate) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine sulfate also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes[1]. Glucosamine sulfate (D-Glucosamine sulfate) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine sulfate also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes[1].